UA-Glo® Bio-luc Luciferase Assay System: A high-throughput luciferase reporter gene detection platform that does not require cell lysis
Reporter gene assays are a core experimental technique for studying gene expression regulation, signal pathway transduction, and drug screening. Among them, firefly luciferase is widely used due to its high sensitivity, wide dynamic range, and ease of detection.
- Recent Advances
- Product Information
I. Overview: Redefining Convenience and Data Quality in Reporter Gene Assays
Reporter gene assays are a core experimental technique for studying gene expression regulation, signal transduction pathways, and drug screening. Among these, firefly luciferase is widely used due to its high sensitivity, broad dynamic range, and ease of detection. However, traditional dual-luciferase reporter gene assay systems typically require cumbersome cell lysis steps, which are time-consuming, limit throughput, and may introduce experimental variability due to inconsistent lysis efficiency.
The UA-Glo® Bio-luc Luciferase Assay System is an innovative detection kit based on a proprietary engineered luciferase (Bio-luc). Its core design principle involves directed modification of traditional firefly luciferase to enable efficient cell membrane penetration and utilization of cellular ATP as an energy source, allowing direct catalysis of substrate luminescence in live cells or lysis-free systems. This design philosophy represents a paradigm shift from "endpoint lysis detection" to "live-cell real-time or endpoint homogeneous detection."
II. Core Principles and Components of the System
This system achieves direct, quantitative measurement of intracellular luciferase activity through optimized enzyme-substrate pairs and detection buffers.
Core Components:
Engineered Luciferase (Bio-luc): The system does not provide the protein but instead uses transfected plasmids to enable cells to express a modified variant of firefly luciferase. This variant features enhanced intracellular stability, catalytic efficiency, and optimized reaction kinetics with proprietary substrates.
UA-Glo® Detection Reagent: A ready-to-use, optimized single reagent containing modified D-luciferin substrate, surfactants, and reaction buffer. Its key characteristic is the ability to efficiently penetrate cell membranes while maintaining intracellular environmental stability, supporting enzymatic reactions within cells.
Detection Principle:
In cell culture plates expressing Bio-luc luciferase, an equal volume of UA-Glo® detection reagent is added directly. The reagent rapidly mixes and penetrates cell membranes, where intracellular Bio-luc enzyme immediately utilizes cellular ATP and the permeated substrate to catalyze an oxidation reaction, generating bioluminescent signals. The intensity of this signal is proportional to the amount of active luciferase in the cells, indirectly reflecting the activity of the target gene promoter or the strength of the signaling pathway.
III. Workflow and Core Applications
Standardized Workflow:
Cell Processing and Culture: Transfect plasmids containing the promoter/response element of interest with the downstream Bio-luc reporter gene into cells (e.g., HEK293, HeLa) and culture in 96-well or 384-well plates for experimental treatments (e.g., drug stimulation, gene overexpression/knockdown).
Equilibration and Reagent Addition: Equilibrate the culture plate at room temperature. Add an equal volume of UA-Glo® detection reagent directly to the medium in each well.
Mixing and Incubation: Briefly mix by shaking and incubate at room temperature for 10-60 minutes (time can be optimized) to allow sufficient signal generation and stabilization.
Data Acquisition: Use a compatible multi-mode microplate reader or chemiluminescence detector to measure luminescence (RLU) in each well.
Core Applications:
Gene Transcriptional Regulation Studies: Quantitative analysis of the activity of different promoters, enhancers, or cis-acting elements.
Signal Pathway Functional Validation: Study the activation or inhibition of signaling molecules such as GPCRs, cytokine receptors, and kinases using reporter genes driven by pathway-specific response elements.
Drug Screening: Suitable for high-throughput screening (HTS) of drugs based on reporter genes, enabling the discovery of small-molecule compounds, antibodies, or siRNAs that modulate specific pathways. Its homogeneous, "add-and-read" format significantly improves throughput and efficiency.
Cell Surface Receptor Functional Analysis: Combined with reporter gene systems coupled to membrane receptor activation, study receptor-ligand interactions and downstream signaling.
IV. Technical Advantages Over Traditional Lysis Methods
Simplified Operation, High Throughput: Eliminates lysis, centrifugation, and aliquot steps entirely, reducing experimental time from hours to minutes, making it ideal for large-scale sample screening.
Improved Data Reproducibility: Avoids variability between wells caused by inconsistent lysis operations (e.g., lysis time, shaking intensity), enhancing precision and repeatability.
Compatibility with Live-Cell and Multi-Timepoint Detection: Since lysis is unnecessary, kinetic monitoring at multiple timepoints is theoretically possible (optimization is required to minimize substrate depletion and cytotoxicity).
Direct Integration with Other Assays: After luminescence detection, other medium-based assays (e.g., cell viability CCK-8/MTS) can be performed on the same wells for multiplexed data acquisition.
Reduced Waste and Cross-Contamination Risk: Eliminates the need to transfer lysates, reducing aerosol generation and inter-sample contamination.
V. Key Experimental Considerations
Cell Density and State: Signal intensity heavily depends on cellular ATP levels. Ensure cells are healthy and metabolically active, and optimize plating density for the best signal-to-noise ratio.
Medium Compatibility: While the system is compatible with common serum-containing or antibiotic-free media, certain components (e.g., high concentrations of antioxidants or membrane-permeability-altering compounds) may interfere. Pre-experimental validation is recommended.
Detection Window: Luminescence typically peaks and stabilizes 10-30 minutes after reagent addition. Determine the optimal read time for your experimental system.
Background Control: Always include negative control wells (untransfected reporter gene plasmids) to subtract background luminescence from cells and medium.
VI. Summary
The UA-Glo® Bio-luc Luciferase Assay System represents a significant advancement in reporter gene detection technology toward greater efficiency and reliability. Through ingenious enzyme engineering and reagent formulation, it transforms complex intracellular enzyme activity detection into a single-step homogeneous operation.
Its core value lies in:
Workflow Liberation and Efficiency: Provides an ideal tool for high-throughput functional genomics and drug screening.
Enhanced Data Quality: Standardized, automated workflows reduce human error and improve result reliability.
Expanded Experimental Possibilities: The non-destructive nature enables live-cell dynamic monitoring and multiplexed assays.
For researchers in transcriptional regulation, signaling pathways, and early-stage drug discovery, this system is a powerful platform that significantly optimizes workflows and accelerates progress.













